http://orcid.org/0000-0002-0910-7811
References
- Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:359–386. 10.1002/ijc.2910.
- Mileo AM, Miccadei S. S. Polyphenols as modulator of oxidative stress in cancer disease: new therapeutic strategies. Oxid Med Cell Longev. 2016;2016:6475624.
- Shastry B. SNPs: impact on gene function and phenotype. Methods Mol Biol. 2009;578:3–22.10.1007/978-1-60327-411-1
- Mostert V. Selenoprotein P: properties, functions, and regulation. Arch Biochem Biophys. 2000;376:433–438.10.1006/abbi.2000.1735
- Méplan C, Dragsted LO, Ravn-Haren G, et al. Association between polymorphisms in glutathione peroxidase and selenoprotein P genes, glutathione peroxidase activity, HRT use and breast cancer risk. PLoS ONE. 2013;8:e73316.10.1371/journal.pone.0073316
- Wu H, Lin C, Zha Y, et al. Redox reactions of Sep15 and its relationship with tumor development. Ai Zheng. 2003;22:119–122.
- Hu Y, Korotkov K, Mehta R, et al. Distribution and functional consequences of nucleotide polymorphisms in the 3′-untranslated region of the human Sep15 gene. Cancer Res. 2001;61:2307–2310.
- Mostert V, Wolff S, Dreher I, et al. Identification of an element within the promoter of human selenoprotein P responsive to transforming growth factor-β. Eur J Biochem. 2001;268:6176–6181.10.1046/j.0014-2956.2001.02565.x
- Hayashi T, Ueno Y, Okamoto T. Oxidoreductive regulation of nuclear factor kappa B. Involvement of a cellular reducing catalyst thioredoxin. J Biol Chem. 1993;268:11380–11388.
- Pellatt A, Wolff R, John E, et al. SEPP1 influences breast cancer risk among women with greater native American ancestry: the breast cancer health disparities study. PLoS ONE. 2013;8:e80554.10.1371/journal.pone.0080554
- Geybels MS, Hutter CM, Kwon EM, et al. Variation in selenoenzyme genes and prostate cancer risk and survival. Prostate. 2013;73:734–742.10.1002/pros.22617
- Al-Taie OH, Uceyler N, Eubner U, et al. Expression profiling and genetic alterations of the selenoproteins GI-GPx and SePP in colorectal carcinogenesis. Nutr Cancer. 2004;48:6–14.10.1207/s15327914nc4801_2
- Sutherland A, Kim D-H, Relton C, et al. Polymorphisms in the selenoprotein S and 15-kDa selenoprotein genes are associated with altered susceptibility to colorectal cancer. Genes Nutr. 2010;5:215–223.10.1007/s12263-010-0176-8
- Penney KL, Schumacher FR, Li H, et al. A large prospective study of SEP15 genetic variation, interaction with plasma selenium levels, and prostate cancer risk and survival. Cancer Prev Res (Phila). 2010;3:604–610.10.1158/1940-6207.CAPR-09-0216
- Jablonska E, Gromadzinska J, Sobala W, et al. Lung cancer risk associated with selenium status is modified in smoking individuals by Sep15 polymorphism. Eur J Nutr. 2008;47:47–54.10.1007/s00394-008-0696-9
- Jablonska E, Gromadzinska J, Peplonska B, et al. Lipid peroxidation and glutathione peroxidase activity relationship in breast cancer depends on functional polymorphism of GPX1. BMC Cancer. 2015;15:1126–657.10.1186/s12885-015-1680-4
- Meplan C, Hughes DJ, Pardini B, et al. Genetic variants in selenoprotein genes increase risk of colorectal cancer. Carcinogenesis. 2010;31:1074–1079.10.1093/carcin/bgq076